Welcome to the International Congress of IASGO


In the name of IASGO – International Association of Surgeons, Gastroenterologists, and Oncologists – it is a particular pleasure for me inviting you to the 24th World Congress of IASGO in Vienna from December 3 – 6, 2014. PROGRAM

This Congress will take place at the Vienna Hofburg Congress Center and will focus on the topic „Multidisciplinary Treatment of GI Cancer”. Specialists and opinion leaders from across the world have agreed to attend and will present state‐of‐the‐art developments and the most recent results.
We established a stimulating program with special consideration to the importance of interdisciplinary cooperation in the field of Gl cancer.
We expect attendants from more than 45 countries to ensure a top level of scientific exchange, but simoultaneously allowing time for the intercommunication of new ideas and the building and set‐up of new networking structures. Besides these medical tasks, however, the accompanying program provides oppotunities for making new friends, deepen friendships and simply come closer across the continents. Vienna is at its very best in December abounding with a variety of historical and cultural highlights. The pre‐Christmas time in Vienna repletes with characteristic Christmas markets and lends this meeting a setting redolent with atmosphere.
Béla Teleky, MD, FRCS
President of the 2014 IASGO – Congress


Welcome to the International Congress of IASGO in Vienna, Austria from December 3 – 6, 2014. An emphasis will be placed on the need for multidisciplinary cooperation between surgeons, oncologists, scientists and health professionals to improve the outcome and experience for patients with GI malignancies. Interactive and educational discussions will focus on controversial areas of treatment including rare tumors as GIST and NET. Interactive debates and video sessions will give you an overview and intensify the knowledge of modern treatment concepts of today.
Scientific Agenda:
The 2014 Congress will feature
– Prevention, early detection and molecular diagnostic strategies for GI malignancies
– Recent advances in radiation therapy, surgery and systemic therapies for upper and lower GI cancer
– The use of molecular biomarkers for the diagnosis and treatment of GI cancer
– Personalized treatment with new agents and predict efficacy of recent developed agents
– Multidisciplinary approaches in the management of patients with GI malignancies including liver transplantation
Abstract deadline: September 1, 2014 (All submissions must be in English)